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Background. Aim was to investigate whether the degree of patient activation of patients with type 2 diabetes (T2D) is different
between men and women. Furthermore, we investigated which factors are associated with patient activation in men and women.
Methods. This cross-sectional study included 1615 patients with T2D from general practices. Patient activation was measured with
the Patient ActivationMeasure (PAM) questionnaire.Multivariate linear regression analyses were used to investigate the association
between gender and patient activation. Stratified analyses according to gender were performed to investigate which factors are
associatedwith patient activation.Results.No association between gender and PAMscorewas found after adjustment for all selected
confounders (𝑝 = 0.094). In men, lower age (𝑝 = 0.001), a higher WHO-5 score (𝑝 < 0.001), and a lower BMI (𝑝 = 0.013) were
associated with a higher PAM score. In women, a higherWHO-5 score (𝑝 < 0.017) and the absence ofmacrovascular complications
(𝑝 < 0.031) were associated with a higher PAM score. Conclusion.There is no difference in the degree of patient activation of men
and women with T2D. Age, well-being, and BMI were found to be associated with patient activation in men, whereas well-being
and macrovascular complications were found to be associated with patient activation in women.
1. Introduction
Patient participation is essential to achieve and maintain
good overall and diabetes control. The Association of Amer-
ican Diabetes Educators (AADE) has defined 7 self-care
behaviours, which are essential for successful and effective
diabetes self-management. These are healthy eating, being
active, taking medication, monitoring, problem solving,
healthy coping, and reducing risks of diabetes-related com-
plications [1].
Not all subjects with type 2 diabetes (T2D) are equally
capable of performing these self-care tasks as performing
these tasks requires knowledge, discipline, and perseverance.
To measure someone’s ability to take control of his or her
own health, Hibbard et al. developed the Patient Activation
Measure (PAM) questionnaire [2, 3]. They have defined
patient activation as someone’s knowledge, skills, and
confidence needed for self-management [2]. According to
the developers, patients go through four stages of patient
activation and every stage needs a different approach. Patient
activation starts with convincing patients that their own
actions can have a positive influence on health. Subsequently,
attention should be paid to obtaining an adequate knowledge
base for making good choices. Thirdly, attention should be
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given to confidence building by achieving success in very
small behavioural modification steps. In the final stage,
attention should be given to extending and maintaining of
behaviour change [4].
A lower PAM level could possibly lead to poorer health
outcomes, as studies have shown that a lower PAM level is
associated with poorer HbA1c control, fewer feet checks and
eye examinations, lower rates of regular physical exercise, and
more use of hospital resources [4–6].
Studies concerning differences in patient activation
between men and women with chronic diseases show con-
tradictory results [6–10]. Two studies found a higher level
of patient activation in men [7, 9], whereas three other
studies did not find a difference between men and women
in the level of patient activation [6, 8, 10]. However, all
of these studies did not adjust for some important factors,
which could have influenced the relation between gender and
patient activation. Women with T2D have a lower degree of
well-being, a lower health-related quality of life, and a higher
body mass index (BMI) and use more often insulin whereas
they are less often smokers and have less macrovascular com-
plications compared to men with T2D [11–13]. Well-being,
physical health status, and BMI are all associated with patient
activation [8]. Therefore, we hypothesized that differences in
patient activation betweenmen andwomenmight possibly be
influenced by well-being, quality of life, and lifestyle factors.
If differences in patient activation between men and women
exist, this may indicate that the level of self-management
tasks should be more gender specific to achieve optimal
health outcomes in both genders. It is unknown whether
there are other factors associated with patient activation in
men or women. Identifying these associations may indicate
gender specific factors to focus on when improving patient
activation. Therefore, the aim of our study was to investigate
whether the level of patient activation differs between men
and women with T2D. Furthermore, we have investigated
whether there are other factors associated with degree of
patient activation in men compared to women.
2. Materials and Methods
2.1. Study Population and Setting. The study population con-
sisted of patients with T2D who were treated in primary care
in three regions in the eastern part of the Netherlands. These
patients were approached for a quality assessment concerning
patient satisfaction performed by Medrie, an organization
which facilitates and supports general practitioners (GPs).
All patients were asked by their care provider to fill out a
survey including questionnaires on quality of life, level of
patient activation, and experience with the received care.
Patientswere included in the period from July 2014 until April
2015. A total of 5925 sets of questionnaires were sent to all
general practices in the regions together. All general practices
were asked to invite patients with T2D to fill out these
questionnaires. Finally, 2319 patients with T2DMgavewritten
informed consent.The other patients refused participation or
the GPs did not include the requested number of patients.
The final study sample consisted of 1688 (72.8%) patients; see
for more details the flowchart in Figure 1.
2.2. Patient Activation Questionnaire. In this study the Dutch
version of the PAM was used which was validated by
NIVEL (Netherlands Institute for Health Services Research)
[9]. The questionnaire consists of 13 items which measure
knowledge, skills, confidence, and behaviours needed for self-
management. Each itemhas five different response categories:
(1) disagree strongly, (2) disagree, (3) agree, (4) agree strongly,
and (5) not applicable. In the current study, the same scoring
rules as in the Dutch validation study of the PAM were
used [9]. Patients who filled out less than 7 items or who
answered all items with disagree strongly or agree strongly
were excluded. Subsequently, mean scores for the PAM were
calculated leaving out items which were responded to with
not applicable.Themean scoreswere transformed into a PAM
score ranging from 0 to 100 based on scoring rules of Insignia
Health [14]. Based on the same rules, the PAM score was also
converted into the four levels of patient activation.
2.3. Data Collection. All patients filled out a survey which
consisted of the PAM questionnaire for measuring degree of
patient activation, theWHO-5 formeasuring well-being, and
the EQ5D for measuring quality of life [15–17]. The WHO-5
questionnaire consists of descriptions of five different positive
feelings: “I have felt cheerful and in good spirits,” “I have
felt calm and relaxed,” “I have felt active and vigorous,” “I
woke up feeling fresh and rested,” and “my daily life has been
filled with things that interest me.” Each feeling has 6 answer
options ranging from 0 (not present) to 5 (constantly present)
[15]. The EQ5D measures health-related quality of life on
five health dimensions: mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression. Each dimension
has 3 answer options: no problems, some problems, and
extreme problems [16]. In this study, the sum scores for the
WHO-5 and EQ5D were used.
Demographic and clinical data were collected from the
personal health record systems of the GPs. These data were
collected during the annual check-up of the patients by their
GP and were already routinely sent to the Diabetes Centre
(Zwolle, theNetherlands) for benchmark and study purposes.
Clinical data that were collected in the period from 9months
before till 5 months after the questionnaire were used. The
following data were extracted: age, gender, diabetes duration,
BMI, smoking status, HbA1c, use of glucose lowering med-
ication, and the presence of micro- and/or macrovascular
complications. The presence of microvascular complications
was defined as having microalbuminuria, diabetes retinopa-
thy, and/or diminished sensibility of the feet. The presence
of macrovascular complications was defined as (a history
of) angina pectoris, myocardial infarction, percutaneous
transluminal coronary angioplasty, coronary artery bypass
grafting, stroke or transient ischemic attack, or the use of
thrombocyte aggregation inhibitors.
2.4. Statistical Analysis. Statistical analyses were performed
using SPSS version 22 (IBMCorporation, Somers, NY, USA).
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5,925 questionnaires were sent
to all general practices together
(i) 3,462 patients were not asked
by their care provider to
participate or refused to participate
(ii) 144 patients were not registered as
primary care treated T2DM patients
(i) 566 patients did not fill in the
questionnaire(s)
(ii) 65 patients had no medical
data in the defined period
of the PAM questionnaire or
answered all questions with disagree
2,319 patients with T2DM gave
written informed consent
1,615 patients were included in
the present study
(iii) 73 patients filled out <7 items
strongly or agree strongly
Figure 1: Flowchart of inclusion.
Multiple imputations were used for missing data on the
independent variables, assuming that datawasmissing at ran-
dom (MAR) or completely at random (MCAR). Ten imputed
datasets were created and the pooled results are described.
The patient characteristics are expressed as mean with stan-
dard deviation (SD) ormedianwith interquartile range (IQR)
for normally distributed and nonnormally distributed data,
respectively. Categorical variables are described in numbers
and percentages. Differences were considered to be signifi-
cant at a𝑝 value of<0.05.The association between gender and
patient activation was investigated with multivariate linear
regression using the continuous PAM score. Four models
were used: (1) a crude model, (2) a model adjusted for age,
(3) a model adjusted for age, well-being, quality of life, BMI,
smoking, presence of macrovascular complications (MVC),
and the use of insulin, and (4) an explorative model with
all variables in model (3) and the following diabetes-related
factors: HbA1c, diabetes duration, use of oral glucose lower-
ing drugs, and the presence of microvascular complications.
These diabetes-related confounders were added to investigate
whether the burden of T2D may confound the relation
between gender and PAM. Interaction was tested at the 0.10
probability level between gender and well-being, gender and
quality of life, gender and BMI, and gender and smoking
in models (3) and (4). Interaction terms were only tested
if interaction was plausible based on theoretical grounds,
and they were only included in the fully adjusted model
when they were statistically significant. Stratified analyses
according to gender were performed to investigate which
factors are associated with patient activation in men and
women. For this purpose,model (3) andmodel (4) were used.
The degree to which the different models determined the
PAM score was evaluated by the explained variance, shown
as adjusted𝑅2. Before analyses, theWHO-5 and EQ5D scores
were tested for presence of multicollinearity.
2.5. Ethical Approval. All patients gave written informed
consent for the use of the survey data and the clinical data.
According to Dutch guidelines this research does not fall
under the scope of the Medical Research Involving Human
Subjects Act, and therefore this study does not need a
formal approval of an accredited METC (The Medical Ethics
Committee of the Isala, Zwolle, the Netherlands).
3. Results
3.1. Patient Characteristics. The patient characteristics are
described in Table 1. Fifty-four percent of the patients were
male. Mean age was 67.1 (SD: 9.2) years in men and 68.9
(SD: 10.1) years in women, who were significantly older than
men (𝑝 < 0.001). Men had significantly higher scores on the
WHO-5 and EQ5Dquestionnaires compared towomen.Men
smokedmore frequently and they had alsomore oftenmicro-
and macrovascular complications compared to women. The
BMI was significantly higher in women. A higher percentage
of men used oral glucose lowering drugs.
3.2. Association of Gender. The median PAM score and the
distribution of the PAM levels are described in Table 1. The
median PAM score was 55.6 (IQR: 51.0–63.1) in men and
55.6 (IQR: 48.9–61.9) in women. The distribution of the
PAM levels did not significantly differ between men and
women (𝑝 = 0.294).The results of the regression analyses are
described in Table 2. In all models gender was not associated
with the PAM score. In the final model (model (3)) a lower
age (𝑏 = −0.13; 𝑝 < 0.001), a higher WHO-5 score (𝑏 = 0.16;
𝑝 < 0.001), and a lower BMI (𝑏 = −0.16; 𝑝 < 0.010) were
associated with a higher PAM score. No interaction was
found between gender and WHO-5 score, gender and EQ5D
score, gender and BMI, and gender and smoking. In the
explorative model (model (4)), all diabetes-related factors
(HbA1c, diabetes duration, use of oral glucose lowering
drugs, and the presence ofmicrovascular complications)were
not associated with the PAM score. Adding these diabetes-
related variables did not significantly affect the results of
model (3).
4 Journal of Diabetes Research
Table 1: Patient characteristics.
Men Women 𝑝 value
𝑛 (%) 874 (54.1) 741 (45.9) —
Mean age (years) 67.1 (9.2) 68.9 (10.1) <0.001
Median WHO-5 score 76 (60–80) 72 (52–80) <0.001
Median EQ5D score 0.9 (0.8–1.0) 0.8 (0.8–1.0) <0.001
Median BMI 28.0 (26.0–31.4) 30.0 (26.7–34.0) <0.001
Smoking, 𝑛 (%) 136 (15.6) 73 (9.9) 0.001
MVC, 𝑛 (%) 411 (47.0) 244 (32.9) <0.001
Use of glucose lowering drugs, 𝑛 (%) 697 (79.7) 560 (75.6) 0.047
Use of insulin, 𝑛 (%) 144 (16.5) 133 (17.9) 0.466
Median diabetes duration 8.3 (4.8–12.1) 8.3 (4.4–12.7) 0.884
Median HbA1c (mmol/mol) 50 (45–56) 51 (45–57) 0.426
Microvascular complications, 𝑛 (%) 401 (45.9) 292 (39.4) 0.006
Median PAM score 55.6 (51.0–63.1) 55.6 (48.9–61.9) 0.235
PAM level 0.294
1 151 (17.3) 131 (17.7)
2 200 (22.9) 187 (25.2)
3 433 (49.5) 334 (45.1)
4 90 (10.3) 89 (12.0)
Values are depicted as 𝑛 (%), mean (SD), or median (IQR). Continuous data were analysed using independent 𝑡-tests or the Mann-Whitney𝑈 test. Categorical
variables were analysed using Chi-square tests.
BMI: body mass index; MVC: macrovascular complications.
Number of patients with missing values: WHO-5: 15, EQ5D: 46, BMI: 23, smoking: 25, MVC: 352, diabetes duration: 8, HbA1c: 22, and microvascular
complications: 352.
3.3. Stratified Analyses According to Gender. Stratified anal-
yses according to gender are described in Table 3. In men,
lower age (𝑏 = −0.18; 𝑝 = 0.001), a higher WHO-5 score
(𝑏 = 0.15; 𝑝 < 0.001), and a lower BMI (𝑏 = −0.220; 𝑝 =
0.013) were associated with a higher PAM score in model (3)
(𝑅2 8.5%). In women, a higher WHO-5 score (𝑏 = 0.17; 𝑝 <
0.001) and the absence of macrovascular complications (𝑏 =
−2.35; 𝑝 < 0.031) are associated with a higher PAM score
in model (3) (𝑅2 10.7%). In the explorative model (model
(4)), no associations were found between HbA1c, diabetes
duration, use of oral glucose lowering drugs, the presence of
microvascular complications, and the PAM score in men or
women.
4. Discussion
The results of this study show that no difference in degree
of patient activation was found between men and women
with T2D treated in primary care. Within men, age, well-
being, and BMI were found to be associated with degree of
patient activation whereas, in women, well-being and MVC
were related to patient activation.
Although some studies have investigated differences in
patient activation betweenmen and women [6–10], our study
is the first study having investigated this relationship in par-
ticular. Two other Dutch studies among patients with chronic
diseases found a slightly higher level of patient activation
in men [7, 9]. Another Dutch study among patients with
chronic diseases could not indicate gender as an explanatory
determinant for patient activation [8]. Furthermore, two
studies from the USA in patients with T2D could also not
ascertain a relation between gender and patient activation
[6, 10]. However, all of these studies did not adjust for
gender-related confounders. Women with T2D have a lower
degree of well-being, a lower health-related quality of life,
and a higher BMI compared to men with T2D [11, 12]. Well-
being, physical health status, and BMI are all associated with
patient activation [8]. Therefore, these factors may confound
the effect of gender on patient activation. Although these
factors differ between men and women in our present study,
adjusting for these factors did not influence the relation
between gender and patient activation.
We found that a lower degree of well-beingwas associated
with a lower level of patient activation in both men and
women. It attributed for 73% and 90% to the explained
variance in the final model in men and women, respectively
(data not shown). Although a strong association between
well-being and patient activation seems to be present, the
effect of well-being is rather small as the total explained
variance was only 8.4% and 10.4% in the final models for
men and women, respectively. A low degree of well-being
could indicate the presence of depression, which was found
to be associated with patient activation in a previous Dutch
study among patients with chronic diseases [8, 18]. This
association is not surprising as one can imagine that the
inability to feel pleasure (anhedonia), which is one of the
main symptoms of depression, will lead to a low level of
patient activation [19]. On the other hand, patients with low
patient activation are less capable of performing adequate
self-management tasks which may lead to lower well-being.
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The direction of this association should be investigated in
further research. The relationships in men between a lower
age and a lower BMI with a higher level of patient activation
are in line with the results of previous studies [7, 8]. The
relation between macrovascular complications and patient
activation, which was found in women in the present study,
has not been investigated before. Whether this association is
actual gender specific or more amatter of coincidence should
be investigated in further research.
Some limitations need to bementioned. Due to the cross-
sectional design, causal conclusions could not be drawn.
Furthermore, although we have investigated important con-
founders, still some potentially important factors were not
taken into account.Wewere not able to adjust for educational
level, socioeconomic status, and marital status. Inclusion
of those variables might increase the explained variance.
Educational status and financial distress, which could be used
as markers for socioeconomic status, were associated with
patient activation in a previous Dutch study [8]. In the same
study, living together versus alone was not associated with
patient activation. It should be investigated further whether
adjusting for these factors will lead to a difference in patient
activation between men and women. At last, selection bias
could have occurred.However, no differencewas found in age
or degree of glycaemic control between the study population
and the whole T2D population from the three regions.
As no differences between patient activation level
between men and women exist, there is no indication that
the approach to men and women with respect to self-
management tasks should be different. However, this does
not directly mean that the same self-care tasks could be
given to men and women, as the effectiveness of self-
care interventions could still be different. This should be
investigated in further research.
5. Conclusion
There is no difference in the degree of patient activation
of men and women with T2D. Furthermore, no significant
influence was found for well-being, quality of life, BMI, and
smoking on the relationship between gender and patient
activation. Age, well-being, and BMI were found to be asso-
ciated with patient activation inmen, whereas well-being and
macrovascular complications were found to be associated
with patient activation in women. Based on these results,
there is no indication that different levels of self-management
tasks should be given to men and women with T2D.
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